North America Latent TB Detection Market to Grow at a CAGR of 5.5% to reach US$ 748.25 Million from 2020 to 2027
The North America latent TB detection market is expected to grow from US$ 513.29 million in 2020 to US$ 748.25 million by 2027; it is estimated to grow at a CAGR of 5.5% from 2020 to 2027.
The US, Canada, and Mexico are economies in North America. Growing prevalence of tuberculosis is expected to surge the market growth. Tuberculosis (TB) can stay dormant for years before developing into an active TB disease. This condition is known as latent TB. Diagnosis of latent TB is imperative, as it will develop into infectious TB disease when the immune system becomes weak. The World Health Organization (WHO) stated that a total of 1.4 million people died from TB in 2019, making TB one of the top 10 causes of mortality in the region. The data also stated that in 2019 TB affected millions of people in the region, of which 56% were adult males, 32% were adult females, and 12% were children. The disease is prevalent in all age groups in the region. Furthermore, according to the Global Health Education (GHE), a registered charity group, the high TB burden countries accounted for 86% of the estimated cases across the region. The US and Canada are among the countries that are highly affected with TB across the region. Therefore, the high prevalence of TB is driving the need for TB tests, in turn, propelling the growth of the North America latent TD detection market. In case of COVID-19, North America is highly affected specially the US. North America has been witnessing a growing number of COVID-19 cases since its outbreak. As per the CDC, In the US, up to 13 million people may have latent tuberculosis infection. Testing for and treating LTBI is the most effective way to prevent TB infection. Recommended by the CDC, IGRA technology is the required method of TB testing for US Citizenship and Immigration Services (USCIS) immigration exams. The COVID-19 pandemic has threatened the national TB programs worldwide. The WHO have also notified that pandemic is threatening to reverse global progress against tuberculosis. The US is also being affected by the COVID-19 with regards to TB management. CDC’s Division of Tuberculosis Elimination (DTBE) funds 61 state, local, and territorial tuberculosis programs in the US through the TB Elimination and Laboratory cooperative agreement. In April 2020, as part of routine monitoring, CDC communicated with 50 of the 61 (82%) grantees to estimate the effect of COVID-19 on essential TB activities. The observations suggested that the COVID-19 response is diverting resources from essential TB elimination activities. The COVID-19 response has affected multiple sectors of public health, recommended preventive screening, and clinical care in the region. In some TB centers (Mexico), the hospital patient intake system was modified to support COVID-19 admissions, thus severely hindering TB services. In some centers, screening for LTBI was considered a lower priority than screening for COVID-19.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America latent TB detection market. The North America latent TB detection market is expected to grow at a good CAGR during the forecast period. 
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
North America Latent TB Detection Market Segmentation
North America Latent TB Detection Market – By Test
- Tuberculin Skin Test (TST)
- Interferon Gamma Released Assay (IGRA)
North America Latent TB Detection Market – By End User
- Hospitals
- Diagnostic Centers
- Laboratories
- Others
North America Latent TB Detection Market, by Country
- US
- Canada
- Mexico
North America Latent TB Detection Market -Companies Mentioned
- Abbott
- ARKRAY, Inc.
- BD
- bioMerieux SA
- F. HOFFMANN-LA ROCHE LTD.
- Lionex GmbH
- Oxford Immunotec Ltd
- QIAGEN
- Serum Institute of India Pvt. Ltd.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Test and Interferon Gamma Released Assay and End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
US, Canada
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Latent TB Detection Market – By Test
1.3.2 North America Latent TB Detection Market – By End User
1.3.3 North America Latent TB Detection Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Latent TB Detection Market – Market Landscape
4.1 Overview
4.2 North America PEST Analysis
5. North America Latent TB Detection Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Prevalence of Tuberculosis
5.1.2 Increasing Government Initiatives to Promote Tuberculosis Detection
5.2 Market Restraints
5.2.1 Presence of Multidrug Resistant Tuberculosis (MDR-TB)
5.3 Market Opportunities
5.3.1 Growth in Emerging Economies
5.4 Future Trends
5.4.1 Rising Advancements in Tuberculosis Diagnosis
5.5 Impact Analysis
6. Latent TB Detection Market – North America Analysis
6.1 North America Latent TB Detection Market Revenue Forecast and Analysis
7. North America Latent TB Detection Market Analysis – By Test
7.1 Overview
7.2 North America Latent TB Detection Market Share, by Test, 2019 and 2027 (%)
7.3 Tuberculin Skin Test (TST)
7.3.1 Overview
7.3.2 Tuberculin Skin Test (TST): Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)
7.4 Interferon Gamma Released Assay (IGRA)
7.4.1 Overview
7.4.2 Interferon Gamma Released Assay (IGRA): Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)
8. North America Latent TB Detection Market Analysis – By End User
8.1 Overview
8.2 North America Latent TB Detection Market Share, by End User, 2019 and 2027 (%)
8.3 Hospitals
8.3.1 Overview
8.3.2 Hospitals: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)
8.4 Diagnostic Centers
8.4.1 Overview
8.4.2 Diagnostic Centers: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)
8.5 Laboratories
8.5.1 Overview
8.5.2 Laboratories: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)
9. North America Latent TB Detection Market Analysis and Forecasts To 2027 – Country Analysis
9.1 North America: Latent TB Detection Market
9.1.1 Overview
9.1.2 North America: Latent TB Detection Market, by Country, 2019 & 2027 (%)
9.1.3 US: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.1.3.1 US: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.1.3.2 US: Latent TB Detection Market, by Test – Revenue and Forecast to 2027 (USD Million)
9.1.3.3 US: Latent TB Detection Market, by End User – Revenue and Forecast to 2027 (USD Million)
9.1.4 Canada: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.1.4.1 Canada: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.1.4.2 Canada: Latent TB Detection Market, by Test – Revenue and Forecast to 2027 (USD Million)
9.1.4.3 Canada: Latent TB Detection Market, by End User – Revenue and Forecast to 2027 (USD Million)
9.1.5 Mexico: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.1.5.1 Mexico: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
9.1.5.2 Mexico: Latent TB Detection Market, by Test – Revenue and Forecast to 2027 (USD Million)
9.1.5.3 Mexico: Latent TB Detection Market, by End User – Revenue and Forecast to 2027 (USD Million)
10. Impact of COVID-19 Pandemic on North America Latent TB Detection Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
11. Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 QIAGEN
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 bioMerieux SA
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 F. HOFFMANN-LA ROCHE LTD.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 BD
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Abbott
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Oxford Immunotec Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Lionex GmbH
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 ARKRAY, Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Serum Institute of India Pvt. Ltd.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Latent TB Detection Market – Revenue, and Forecast to 2027 (US$ Million)
Table 2. US: Latent TB Detection Market, by Test – Revenue and Forecast to 2027 (USD Million)
Table 3. US: Latent TB Detection Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 4. Canada: Latent TB Detection Market, by Test – Revenue and Forecast to 2027 (USD Million)
Table 5. Canada: Latent TB Detection Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 6. Mexico: Latent TB Detection Market, by Test – Revenue and Forecast to 2027 (USD Million)
Table 7. Mexico: Latent TB Detection Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 8. Organic Developments Done By Companies
Table 9. Inorganic Developments Done By Companies
Table 10. Glossary of Terms
LIST OF FIGURES
Figure 1. North America Latent TB Detection Market Segmentation
Figure 2. North America Latent TB Detection Market – By Country
Figure 3. North America Latent TB Detection Market Overview
Figure 4. Interferon Gamma Released Assay (IGRA) Segment Held Largest Share of North America Latent TB Detection Market
Figure 5. US to Show Remarkable Growth During Forecast Period
Figure 6. North America PEST Analysis
Figure 7. North America Latent TB Detection Market Impact Analysis of Drivers and Restraint
Figure 8. North America Latent TB Detection Market – Revenue Forecast and Analysis
Figure 9. North America Latent TB Detection Market Share, by Test, 2019 and 2027 (%)
Figure 10. North America Tuberculin Skin Test (TST): Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)
Figure 11. North America Interferon Gamma Released Assay (IGRA): Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)
Figure 12. North America Latent TB Detection Market Share, by End User, 2019 and 2027 (%)
Figure 13. North America Hospitals: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)
Figure 14. North America Diagnostic Centers: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)
Figure 15. North America Laboratories: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)
Figure 16. North America Others: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)
Figure 17. North America: Latent TB Detection Market, by Key Country – Revenue (2019) (USD Million)
Figure 18. North America: Latent TB Detection Market, by Country, 2019 & 2027 (%)
Figure 19. US: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
Figure 20. Canada: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
Figure 21. Mexico: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)
Figure 22. Impact of COVID-19 Pandemic in North American Country Markets
- Abbott
- ARKRAY, Inc.
- BD
- bioMerieux SA
- F. HOFFMANN-LA ROCHE LTD.
- Lionex GmbH
- Oxford Immunotec Ltd
- QIAGEN
- Serum Institute of India Pvt. Ltd.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For